MedPath
NMPA Approval

Zimberelimab Injection

国药准字S20210034

August 25, 2021

Drug Information

赛帕利单抗注射液

誉妥

注射剂

120mg(4ml)/瓶

生物制品

August 25, 2021

Company Information

Applicant Company

广州市黄埔区南翔三路1号自编二栋综合楼三层

Manufacturing Company

无锡药明生物技术股份有限公司;智享生物技术(苏州)有限公司

江苏省无锡市滨湖区马山梅梁路108号;苏州工业园区春浦路58号新建元汇智湾A5、A6、B1幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

赛帕利单抗注射液 - NMPA 批准文号 | MedPath